Bax-BH3

General Information


DRACP ID  DRACP06008

Peptide Name   Bax-BH3

Sequence  DASTKKLSECLRRIGDELDS

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Pro-apoptosis



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H158N28O35S

Absent amino acids  FHMNPQVWY

Common amino acids  DLS

Mass  257557

Pl  4.64

Basic residues  4

Acidic residues  5

Hydrophobic residues  5

Net charge  -1

Boman Index  -6978

Hydrophobicity  -88

Aliphatic Index  83

Half Life 
  Mammalian: 1 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113549143A

Patent Title  Anti-tumor polypeptide Bax-BH3, fluorescent polymer nano-micelle as well as preparation method and application of fluorescent polymer nano-micelle

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.